Shilpa Medicare Limited (NSE:SHILPAMED)
India · Delayed Price · Currency is INR 640.00
+14.55 (2.33%)
Jul 21, 2026, 3:29 PM IST
Shilpa Medicare Market Cap
Shilpa Medicare has a market cap or net worth of 125.05 billion as of July 21, 2026. Its market cap has increased by 57.35% in one year.
Market Cap
125.05B
Enterprise Value
131.19B
Revenue
15.39B
Ranking
n/a
PE Ratio
51.39
Stock Price
640.00
ChartMarket Cap Chart
Since July 19, 1999, Shilpa Medicare's market cap has increased from 45.10M to 125.05B, an increase of 277,178.08%. That is a compound annual growth rate of 34.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 125.05B | 99.05% |
| Dec 31, 2025 | 62.82B | -11.35% |
| Dec 31, 2024 | 70.86B | 147.08% |
| Dec 29, 2023 | 28.68B | 18.74% |
| Dec 30, 2022 | 24.15B | -48.10% |
| Dec 31, 2021 | 46.54B | 26.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Piramal Pharma | 238.12B |
| Eris Lifesciences | 201.67B |
| NATCO Pharma | 169.26B |
| Cohance Lifesciences | 169.06B |
| Alembic Pharmaceuticals | 162.18B |
| Alivus Life Sciences | 139.10B |
| Akums Drugs and Pharmaceuticals | 101.81B |
| Strides Pharma Science | 99.08B |